Article Details

UC Davis researchers study viability of drug used to treat President Trump

Retrieved on: 2020-10-23 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

UC Davis researchers study viability of drug used to treat President Trump. View article details on HISWAI:

Excerpt

<div>He explained that Regeneron's drug is a cocktail of <b>monoclonal antibodies</b>, which are antibodies made by bacteria that are detected by the immune ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up